Form 8-K - Current report:
SEC Accession No. 0001193125-25-263828
Filing Date
2025-11-04
Accepted
2025-11-04 10:47:59
Documents
15
Period of Report
2025-11-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d60790d8k.htm   iXBRL 8-K 53700
2 EX-99.1 d60790dex991.htm EX-99.1 22577
3 EX-99.2 d60790dex992.htm EX-99.2 19070
7 GRAPHIC g60790g1104193305380.jpg GRAPHIC 1791
  Complete submission text file 0001193125-25-263828.txt   237872

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mtsr-20251103.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtsr-20251103_lab.xml EX-101.LAB 18735
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtsr-20251103_pre.xml EX-101.PRE 11697
17 EXTRACTED XBRL INSTANCE DOCUMENT d60790d8k_htm.xml XML 3769
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 251447095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)